Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 1/2024

Open Access 01.12.2024 | Research

Comparative analysis of linear- and circular-stapled gastrojejunostomies in Roux-en-Y gastric bypass: a focus on postoperative morbidity using the comprehensive complication index

verfasst von: Floni Sadiku, Daniela Alceste, Michele Serra, Stefanie Josefine Hehl, Daniel Gero, Andreas Thalheimer, Marco Bueter, Jeannette Widmer

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 1/2024

Abstract

Purpose

The linear-stapled (LSA) and the circular-stapled anastomosis (CSA) are the two most commonly performed techniques for the gastrojejunostomy (GJ) during laparoscopic Roux-en-Y gastric bypass (RYGB). This study compared the outcome after both techniques with special focus on postoperative morbidity using the comprehensive complication index (CCI).

Methods

Five hundred eighty-eight patients operated between 01/2010 and 12/2019 were included in the final analysis and divided in two cohorts according to the surgical technique of the GJ (LSA (n = 290) or CSA (n = 298)). Before 09/2016, the CSA was exclusively performed for the GJ, while after 09/2016, the LSA was solely used.

Results

The mean CCI for patients with Clavien-Dindo complication grade ≥ 2 within the first 90 days after RYGB was 31 ± 9.1 in the CSA and 25.7 ± 6.8 in the LSA group (p < 0.001), both values still below the previously published benchmark cutoff (≤ 33.73). The C-reactive Protein (CRP)-levels on postoperative days (POD) 1 and 3 as well as the use of opioids on POD 1 were significantly higher in the CSA- than in the LSA-group (all p < 0.001). There were significantly more internal herniations in the CSA group during the first 24 postoperative months (p < 0.001).

Conclusion

Patients after RYGB with CSA were found to have higher CCI values during the first 90 PODs compared to patients in which the LSA was applied. To achieve optimal outcomes in terms of patient morbidity, the LSA seems to be the superior technique for GJ in RYGB.
Hinweise

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Introduction

The laparoscopic Roux-en-Y gastric bypass (RYGB) is one of the most frequently performed metabolic-bariatric surgeries (MBS) worldwide and leads to both sufficient body weight loss and resolution of obesity-associated medical problems [13]. After RYGB became laparoscopically feasible in the late 1990s [4], three techniques for the gastrojejunostomy (GJ) were regularly applied: entirely hand-sewn, hand-sewn combined with linear-stapled (LSA) or entirely circular-stapled anastomoses (CSA). A period of technical refinements followed resulting in significantly shorter operation times for the stapled anastomoses turning them into the gold standard GJ-technique in RYGBs [59]. Comparing the two stapled techniques revealed not only a shorter operation time, but also less anastomotic strictures at the GJ and less wound infections for the LSA [7, 911]. Consequently, a shift from CSA to LSA has been observed over the last few years [12].
However, the reporting of postoperative complications still varies among clinical studies making a comparison of results difficult [1316]. The already well-established Clavien-Dindo classification (CDC) offers a simple tabular form to rate postoperative complications according to the invasiveness of treatment needed to correct a complication [17]. Usually, only the most severe complication is reported with the CDC. Adverse events of lesser severity are however “neglected” and may involve an underestimation of the true overall morbidity of a surgical procedure. To overcome this limitation, the idea of the Comprehensive Complication index (CCI) was developed, which incorporates all postoperative complications graded with CDC in a score from 0 (no complication) to 100 (death). It therefore gives a representative picture of the cumulative postoperative morbidity correlating with overall costs [18] and the patient’s individual burden of several adverse events. We herein present our single-center experience with CSA- and LSA-technique and quantify postoperative morbidity with the CCI, which has not yet been published before.

Material and methods

Data collection and analysis

A prospectively collected database of 968 patients who underwent MBS between 01/2010 and 12/2019 at the University Hospital Zurich was retrospectively reviewed. Included were patients who underwent a primary, laparoscopic RYGB at least 2 years ago (to guarantee a follow-up of 2 years) and were of 18 years or older. Patients who underwent secondary MBS or surgical techniques other than laparoscopic RYGB were excluded. According to the GJ technique, 298 and 290 patients were finally identified in the CSA- or LSA-group, respectively.

Surgical technique

Both anastomotic techniques were standardized as previously described [1922]. All performing surgeons were experienced with at least 50 MBS in total.
For CSA, which was the standard technique between 01/2010 and 08/2016, a gastric tube with the anvil of the 25 mm-circular stapler (Metronic – former Covidien—EEA™ circular stapler) connected to the aboral tube’s end was orally introduced. Laparoscopically, the tube’s tip was extracted over an incision at the previously created small gastric pouch pulling it into the abdominal cavity unraveling the stapler’s head pin. The jejunum was transected 50–70 cm post-Treitz creating a biliopancreatic (BL) and alimentary limb (AL). The BL was placed in the right hemiabdomen and the side-to-side jejunojejunostomy after 150 cm of AL was created (Figs. 1, 3). Skin incision in the middle right abdomen was made over a length of 4–5 cm and the circular stapler was sharply introduced through the abdominal wall into the abdomen and into the antecolic AL via an enterotomy [22]. Then, the extended stapler-pin perforated the intestinal wall anti-mesenterically was connected to the stapler’s head at the gastric pouch and the GJ was created. Removal of the stapler without protection through a small incision (loco typico for surgical site infections (SSI)), which was closed primarily until 09/2013, then secondary closure was pursued [23]. The mesenteric space from the jejunojejunostomy was routinely closed, whereas the Petersen’s space (mesentery of antecolic AL and colon transversum) was kept open (Fig. 3).
For LSA, which became the new standard technique in 09/2016 at our institution, 70 cm of jejunum from the ligament of Treitz was placed on the left side of the abdomen after creating a small gastric pouch, and a 30-mm endoscopic linear stapler was introduced (Figs. 2, 3). The jejunum with the inserted stapler approached the gastric pouch as an antecolic omega-loop and the GJ was created by stapling the jejunum to the posterior wall of the gastric pouch. The remaining defect was closed with running sutures (2xVicryl 4–0). The jejunojejunostomy was built with the BL (70 cm) and the AL (150 cm) side-to-side. To complete the Roux-en-Y construction, the omega-loop was divided with a linear stapler between the GJ and the jejunojejunostomy. Both mesenteric spaces were routinely closed.

Surgical outcome

After surgery, the amount of needed opioid medication was documented and converted into morphine equivalent doses—as an objective parameter for pain perception [24]. Postoperative complications were categorized with the Clavien-Dindo classification (CDC) during hospital stay and during 90 days after surgery (early complications) as well as after 24 months postoperative (late complications) in the outpatient clinic. Complications were diagnosed according to the clinical presentation and included CT-scans, upper endoscopies, dynamic imaging (contrast swallow), and/or diagnostic laparoscopy. Patients with a higher risk for postoperative complications—so-called non-benchmark patients—were retrospectively identified based on the definition previously published (patients with history of previous intra-abdominal surgery, cardiovascular disease, diabetes mellitus, thromboembolic events and/or therapeutic anticoagulation, obstructive sleep apnea, chronic obstructive pulmonary disease, chronic kidney disease, immunosuppression therapy, and/or combined surgery) [25]. The follow-up was held in the outpatient clinic of bariatric surgeons and/or endocrinologists on a regular base. We analyzed all complications during the first 2 years, which were documented rather completely.

Comprehensive Complication Index (CCI)

A limitation of the CDC is that usually only the most severe postoperative complication is reported. Complications of lesser severity are often “ignored.” However, a severe complication usually comes along with additional adverse events, and each contributes to the patient’s recovery, the length of hospital stay, and the overall costs. The lack of a holistic representation of the postoperative course by the CDC led to the development of the CCI in 2013 [26]. This index integrates each complication in the same patient based on the CDC into a score ranging from zero (no complication) to 100 (death) and can be calculated on www.​cci-calculation.​com. For example, a CDC grade I complication such as a wound infection requiring bedside management corresponds to a CCI of 8.7. A combination of a CDC grade I and grade IIIa complication is represented by a CCI of 27.6. Complications requiring a gastroscopy—for example—are usually graded as a CDC grade IIIa either with or without an endoscopic intervention. However, multiple gastroscopies for one diagnosis such as—for example—a GJ-stenosis requiring repetitive dilatation were considered as one complication if they were planned as treatment for the initial complication. A relapse of the GJ-stenosis requiring again endoscopic dilatation was counted as a second event [27].
The mean overall CCI was calculated and compared with indices from patients with complications (excluding those without complications) during hospital stay and after 90-days postoperative. To compare the mean CCI with previous published benchmark papers CDC Grade I complications were in a second calculation excluded. The reason behind excluding CDC Grade I complications is that these “minor” complications are mostly underreported, even in very experienced centers and may weaken the “true” overall CCI [25].

Statistical analysis

Statistical significance was defined as p < 0.05. Continuous data are shown as mean ± standard deviation (SD) as appropriate and categorical as number (n) and percentage (%). Continuous variables normally distributed were compared with the paired t-test. Differences in nominal data were compared by Fisher’s exact test. GraphPad Prism Version 9.1.0 (GraphPad Software, Inc., San Diego, CA) and R version 4.04 (R Core Team) have been used for statistics.

Results

Overall, 588 patients after primary, laparoscopic RYGB were analyzed and divided in two cohorts according to the anastomotic technique for the gastrojejunostomy: 298 patients with CSA and 290 patients with LSA. All included patients completed a follow-up of at least 2 years. Patients in the LSA-group were significantly older (41.4 vs 37.1 years, p < 0.001), more frequently female (75.9% vs 48.7%, p < 0.001) and underwent more previous abdominal surgery (45.5% vs 27.2%, p < 0.001). The mean preoperative BMI was comparable with 44.8 ± 6.3 kg/m2 in the CSA- and 44 ± 7 kg/m2 in the LSA-group (p = 0.061) (Table 1).
Table 1
Preoperative data and patient’s risk profile
 
CSA (n = 298)
LSA (n = 290)
p-value
Age (years)
37.1 ± 10.6
41.4 ± 12.54
 < 0.001
Male
153 (51.3)
70 (24.1)
 < 0.001
Preoperative BMI (kg/m2)
44.8 ± 6.3
44 ± 7
0.061
OSAS
87 (29.2)
89 (30.7)
0.76
Hypertension
195 (65.4)
156 (53.8)
0.005
Prediabetes/ T2DM
124 (41.6)
103 (35.5)
0.15
Previous abdominal surgery
81 (27.2)
132 (45.5)
 < 0.001
Low-risk patients*
80 (26.8)
66 (22.8)
0.25
Data is presented as N (%) or mean ± SD, CSA = circular-stapled anastomosis, LSA = linear-stapled
anastomosis, OSAS = obstructive sleeping apnea syndrome, T2DM = type 2 diabetes mellitus
*according to the Benchmarks in Bariatric Surgery [24]

Postoperative outcome

As shown in Table 2, the median operation time was significantly shorter for laparoscopic RYGB with LSA compared to CSA with 95.6 ± 24.5 min vs 127 ± 34.9 min (p < 0.001), respectively. The mean use of opioids on the first postoperative day was more than three times higher in the CSA- then the LSA-group (19.7 ± 22 vs 6.4 ± 12.3 units, p < 0.001). Postoperative C-reactive protein (CRP) levels were significantly lower in the LSA-group compared to the CSA-group on postoperative day (POD) 1 (33.3 ± 20.7 vs 72.8 ± 36.9 mg/l, p < 0.001) and POD 3 (53.3 ± 37.7 vs 106.2 ± 67.9 mg/l, p < 0.001) (Fig. 4). Overall, 146 (24.8%) patients had a benchmark (low-risk) profile: 80 (26.8%) in the CSA- and 66 (22.8%) in the LSA-group, respectively.
Table 2
Perioperative data and complication rates
   
Benchmark Cutoffs
until 90-d
 
CSA (n = 298)
LSA (n = 290)
p-value
Operation Time
127 ± 34.9
95.6 ± 24.5
 < 0.001
 ≤ 120 min
Use of opioids day 1 (Units)
19.7 ± 22
6.4 ± 12.3
 < 0.001
 
CRP day 1 (mg/l)
72.8 ± 36.9
33.3 ± 20.7
 < 0.001
 
CRP day 3 (mg/l)
106.2 ± 67.9
53.3 ± 37.7
 < 0.001
 
Length of hospital stay
6.5 (6;8)
5 (4;5)
 < 0.001
 ≤ 4d
Patients with early complications°
114 (38.3)
56 (19.3)
 < 0.001
 ≤ 10%
Early major complication grade ≥ IIIa
65 (21.8)
14 (4.8)
 < 0.001
 ≤ 5.5%
Overall early complications°°
167
63
  
   CDC I
34 (20.4)
14 (22.2)
0.004
 
   CDC II
46 (27.5)
35 (55.6)
0.281
 
   CDC IIIa
61 (36.5)
5 (7.9)
 < 0.001
 
   CDC IIIb
23 (13.8)
7 (11.1)
0.004
 
   CDC IVa
3 (1.8)
2 (3.2)
 > 0.999
 
   CDC IVb
0
0
  
   CDC V
0
0
  
   CCI overall
26.7 (12.1)
21.9 (9.1)
0.009
 
CCI with CDC ≥ grade II*
31 ± 9.1
25.7 ± 6.8
 < 0.001
 ≤ 33.73
Patients with late complications**
92 (30.9)
56 (19.3)
0.001
 
Data is presented as N (%), mean ± SD or median (Q1;Q3), CSA = circular-stapled anastomosis, LSA = linear-stapled
anastomosis, CDC = Clavien-Dindo Classification, CCI = Comprehensive Complication Index, d = days
*at least 1 complication, ** within two years after bariatric surgery, °all patients suffering from at least one complication during
90 days, °°overall number of complications during 90 days after surgery
Weight loss within 2 years was similar in both groups (initial BMI and BMI after 2 years for LSA- and CSA-group was 44 ± 6.9 kg/m2 and 45 ± 5.8 kg/m2 (p = 0.06), and 30 ± 4.7 kg/m2 and 30.6 ± 6.1 kg/m2 (p = 0.395), respectively. Corresponding to a %TWL of 76.43 ± 22 and 76 ± 24 in the LSA- and CSA-group, respectively (p = 0.889)).

Early complications

During the first 90 POD, 167 complications were documented in 114 (38.3%) CSA- and 63 complications in 56 (19.3%) LSA-patients (Table 2). Sixty-five (21.8%) CSA-patients had CDC grades from IIIa and/or above, while this was the case in 14 (4.8%) LSA-patients. Complications with organ failure (IVa) were documented in three CSA-patients (pulmonary sepsis, myocardial infarction, and cerebral ischemia) and in two LSA-patients (two cardiac events).
The CSA-group showed a significantly higher occurrence of SSI and GJ-stenosis (Table 3). There was no difference for anastomotic leaks or marginal ulcerations at the GJ or for anastomotic bleedings (GJ or jejunojejunostomy) between the two groups. There was no mortality until 24 months after surgery.
Table 3
Postoperative complications
   
Benchmark Cutoffs
until 90 days
 
CSA (n = 298)
LSA (n = 290)
p-value
SSI loco typico (until 90 days)
34 (11.4)
3 (1.0)
 < 0.001
 ≤ 0.5%
primary wound closure*
26 (76.5)
   
secondary wound closure**
8 (23.5)
   
GJ Ulcer
early (until 90 days)
11 (3.7)
14 (4.8)
0.544
 ≤ 1.5%
days after surgery
49.9 ± 23.9
63.2 ± 24.9
0.200
 
late (3–24 months)
31 (10.4)
27 (9.31)
0.680
 
months after surgery
21
11
  
GJ-Stenosis
early (until 90 days)
41 (13.8)
1 (0.3)
 < 0.001
 ≤ 1.2%
late (3–24 months)
10 (3.4)
2 (0.7)
0.037
 
Internal hernia+
early (until 90 days)
3 (1.0)
0 (0)
0.25
 ≤ 2.1%
late (3–24 months)
33 (11.1)
3 (1.0)
 < 0.001
 
repeated internal hernias°
4
0
  
Anastomotic leak (until 90 days)
10 (3.4)
1 (0.3)
0.011
 ≤ 1.3%
Postop. Bleeding (until 90 days)
12 (4.03)
10 (3.45)
0.829
 ≤ 2.2%
Data is presented as N (%) or mean ± SD, CSA = circular-stapled anastomosis, LSA = linear-stapled
Anastomosis, SSI = surgical site infection, GJ = gastrojejunostomy, *before 2013: primary closure of all wounds including loco typico **after 2013: secondary wound closure for loco typico °within two years after surgery
 + including Petersen and Brolin hernia

Comprehensive Complication Index (CCI)

The mean CCI 90 days after surgery for patients with at least one CDC ≥ II complication was in the CSA-group 31 ± 9.1 and 25.7 ± 6.8 in the LSA-group (p < 0.001) (Table 2). The highest CCI in the CSA-group was 58.4 for a patient who needed several surgical interventions for a wound infection. In the LSA-group, the highest CCI was 42.4 in two patients both with one organ failure (lung and heart, respectively).

Late complications

Late complications within the first 2 years after surgery were documented in 92 (30.9%) CSA- and in 56 (19.3%) LSA-patients (p < 0.001), respectively (Table 2). There were significantly more internal herniations in the CSA-group with 33 versus 3 in the LSA-group (p < 0.0001). Four patients had recurrences of internal hernias in the CSA-group compared to none in the LSA-group (Table 3).

Discussion

A shift from circular- to linear-stapled gastrojejunostomies in RYGB has been observed over the last few years. This is the first study, which defines postoperative outcome of the two surgical techniques with the CCI. We found that the cumulative CCI for the first 90 days after RYGB was significantly higher in the CSA- than in the LSA-group, despite more, but not significantly, high-risk patients in the latter cohort. In particular, the incidence of SSI and GJ-stenosis in the early postoperative phase as well as of internal hernias during the first 2 years after MBS were significantly higher in the CSA-group. Remarkably, changes in wound management and closure of all mesenteric spaces equalized the incidence of SSI and internal hernias in the two cohorts. Finally, patients with CSA showed a greater inflammatory response after surgery with higher postoperative CRP-levels and higher postoperative need for opioid analgesics compared to the LSA-group.
The RYGB is a well-established MBS-procedure, and its surgical steps are predominantly standardized with a view to reduce morbidity in patients often with high-risk profiles. Still, routine quality assessment is key to guarantee best achievable outcome for surgeons and patients [28, 29]. The CCI offers a numeric value representing cumulatively all negative events during 90 days after surgery and is routinely applied in our clinic to compare surgical outcome with for example benchmark outcome [25, 30]. The aim of assessing postoperative results is to stimulate surgical improvement. The two surgical techniques for the GJ, which were analyzed in this study, are technically feasible and reach similar weight loss. However, previous analysis demonstrated an advantage for LSA in terms of a lower complication rate. Peterli et al. showed a significant lower GJ-stricture rate for LSA, while Muller et al. demonstrated a better quality of life and less complications overall, less re-hospitalizations and reoperations for the LSA cohort after a 5-year follow-up [11, 31]. Here, we present the data of our high-volume center reflecting the postoperative outcome with the CCI. Overall, the incidence of early complications within the first 90 days after both surgical techniques may seem comparably [32, 33] high in this study with 38.3% in the CSA and 19.3% in the LSA group. This is especially true taking into consideration our own analysis comparing the outcome of benchmark patients demonstrating that 90% of low-risk patients should have an uneventful course during the first 90 days after RYGB [25]. However, there are two factors that need to be considered when interpreting these results. First, the included patient-cohort had a rather high-risk profile at baseline, indicated by more than 80% of the included patients fulfilling the criteria of non-benchmark cases. The incidence of complications could be rather due to patient selection than poor surgical technique. Of note, the mean 90-day CCI of all patients with complications in our analysis is below the published 90-days cut-off value of 33.73—despite the high-risk profile of the included patients [25, 30].
Second, due to the fact that the CDC score was developed by members of our clinic [17, 26], our clinical staff is sensitized to document postoperative complications as accurate as possible. CDC grades of all patients are routinely defined and documented at the moment of discharge by our residents and regularly discussed at our weekly “morbidity and mortality conference” with all senior consultants being present [27]. This may lead to a comparably high overall incidence of postoperative complications in our institution. Nevertheless, CDC grade I complications are even in our clinic underreported and justify a mean CCI calculation with and without CDC grade I complications (Table 2). Especially from the patient’s perspective, CDC grad I complications are usually less impairing than more severe complications and therefore may “dilute” the true CCI. However, the difference of the mean CCI between the two cohorts was surprisingly little. This can be explained by the fact that—for example—SSIs (CDC grade I) have no or almost no impact on CCI calculation and that repetitive interventions (such as gastroscopies, for example) were counted only once if they were planned [27].
In our study, the CSA-group presented significantly more early complications compared to the LSA-group, especially CDC grades higher than II. This fact may be explained by the higher incidence of stenosis at the CSA requiring more diagnostic and therapeutic gastroscopies [12, 34]. By comparison, there was only one stenosis diagnosed during the first 90 days postoperatively in patients of the LSA-group compared to 41 (13.8%) in the CSA-group. GJ-stenosis is a well-known soft spot for circular-stapled GJ [35, 36]. However, in a recent meta-analysis including 22 articles, LSA was not significantly superior to CSA in terms of GJ strictures [37]. This lack of significant difference has already been documented in a previous meta-analysis by Edholm [7]. In. contrast, a nationwide population-based cohort study from the Netherlands including 12,400 patients showed a significantly higher postoperative overall complication rate in the CSA-group, but especially for major bleeding [38]. Several studies including a systematic review confirm the finding of a significant higher postoperative complication rate for CSA—even up to a complication rate of 50% [7, 11, 30, 38]. The wide range and contradictory findings represent the challenge of comparing complication rates due to different reporting mentality and/or study designs.
As previously published by various authors, our data also showed a comparably high incidence of wound infections in the CSA-group [5, 7, 10, 35, 39]. However, this is not entirely unexpected due to the fact, once the CSA is created, the circular stapler device is removed from the inside of the alimentary limb and abdominal cavity without using a specific wound protection. This finding is not related to the CSA technique per se, but connected to the fact that circular staplers must be inserted intraabdominally without skin protection and potentially contaminate the subcutis. Interestingly, after changing our strategy from primary to secondary closure, the wound infection rate in the CSA-group decreased significantly [23]. Thus, adequate wound management seems to equalize the incidence of SSI between the two techniques.
There was also a significant difference of the occurrence of late complications between the two groups, especially for the incidence of internal hernia, which was significantly higher in the CSA group. This observation can be explained by the different strategies in closing the mesenteric defects in both groups. In the CSA-group, only the mesenteric defect at the level of the jejunojejunostomy was closed, while the Petersen’s space remained open. Unsurprisingly, the majority of internal hernias in the CSA-group were herniations through the Petersen’s space, only a few through the jejunojejunostomy’s mesenteric space and/or through both spaces. Accordingly, Stenberg et al. demonstrated 2016 the importance of closing both mesenteric defects to avoid internal herniations [13]. After the introduction of the LSA technique in our clinic—almost simultaneously to Stenberg et al.’s publication—both mesenteric defects were routinely closed during RYGB leading to a reduced incidence of internal hernias thereafter. Our data are in line with a recent meta-analysis and underline the importance of routine closure of all mesenteric defects during RYGB [40, 41]. Another aspect, which may explain why recurrent Petersen-hernias were only seen in the CSA-group, is the location of the biliary limb. For the CSA, the BL was placed on the right side of the abdominal cavity making it undercrossing the antecolic AL, which leads to a “physologically” incomplete closure of the Petersen space. The other way around in the LSA group: the BL is placed on the left side making it easy to close the Petersen space completely (Fig. 3). However, the discussion is still controversial. A recent long-term analysis showed significantly more internal hernia in the circular-stapled gastrojejunostomy group compared to linear-stapled GJ [12]. Whereas the propensity scored matched analysis from 2016 could not show a significant difference [11].
Despite these two technical learning-by-doing improvements (wound management and closure of both mesenteric spaces), early complication rates were not affected very much in our study. Most of SSIs are CDC complication grade I, which will not be counted for the relevant CCI calculation. The inner hernia instead is a late complication and was not part of the CCI calculation.
Further, the CSA-group presented higher CRP-levels postoperatively and needed higher doses of morphine. Both facts suggest a higher surgical stress for the CSA-group when compared to the LSA-group as postoperative CRP levels may be indicative for the amount of tissue damage during an operation [42]. On the other hand, a higher CRP-level postoperative may also go along with the higher incidence of postoperative complications [43, 44]. In addition, more postoperative pain in the CSA-group can be explained by the larger soft tissue trauma due to the insertion of the circular stapler which adds to the higher tissue damage for the CSA technique [22].
Finally, a higher incidence of postoperative complications due to higher surgical stress and/or longer operation time after RYGB with circular-stapled GJs is not only relevant for each individual patient, but also for health systems worldwide when it comes to related costs. This aspect was analyzed in a recent prospective longitudinal cohort study including 385 patients, where the CSA technique was demonstrated to be associated with higher material costs [8]. Additional data from Switzerland show similar results with improved financial outcomes after transition from a circular to a linear stapling protocol in RYGB surgery [12]. The longer operation time in RYGB with CSA, which seems to be attributed to the technique of the procedure, also leads to higher costs [45, 46].
Our study has several limitations. First, there is the retrospective study design including data over a time period of nearly ten years. Second, the CSA- and LSA-techniques were used in a chronological order suggesting that the evolution of perioperative care during the use of the CSA-technique may have contributed to the better outcomes of the LSA-group. Third, there is some heterogeneity regarding the involved surgeons. Further biases may have been generated by changing protocols for wound management and by different strategies for closing the mesenteric defects.

Conclusion

Our data show a higher mean CCI score for the CSA-group 90 days after surgery compared to the LSA-group indicating that the CSA technique is associated with a higher incidence of early postoperative complications when compared to the LSA technique for the GJ in RYGB surgery. Further, the CSA technique seems to provoke more surgical stress as indicated by higher CRP levels and use of opioid analgesia during the first postoperative days.

Declarations

Ethical approval and informed consent

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and cantonal research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Literatur
1.
Zurück zum Zitat Khaodhiar L, McCowen KC, Blackburn GL (1999) Obesity and its comorbid conditions. Clin Cornerstone 2:17–31PubMedCrossRef Khaodhiar L, McCowen KC, Blackburn GL (1999) Obesity and its comorbid conditions. Clin Cornerstone 2:17–31PubMedCrossRef
2.
Zurück zum Zitat Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J et al (2019) Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 29:782–795PubMedCrossRef Welbourn R, Hollyman M, Kinsman R, Dixon J, Liem R, Ottosson J et al (2019) Bariatric surgery worldwide: baseline demographic description and one-year outcomes from the Fourth IFSO Global Registry Report 2018. Obes Surg 29:782–795PubMedCrossRef
3.
Zurück zum Zitat Maclellan WC, Johnson JM (2021) Laparoscopic gastric bypass: still the gold standard? Surg Clin North Am 101:161–175PubMedCrossRef Maclellan WC, Johnson JM (2021) Laparoscopic gastric bypass: still the gold standard? Surg Clin North Am 101:161–175PubMedCrossRef
4.
Zurück zum Zitat Wittgrove AC, Clark GW, Schubert KR (1996) Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3–30 months follow-up. Obes Surg 6:500–4PubMedCrossRef Wittgrove AC, Clark GW, Schubert KR (1996) Laparoscopic gastric bypass, Roux-en-Y: technique and results in 75 patients with 3–30 months follow-up. Obes Surg 6:500–4PubMedCrossRef
5.
Zurück zum Zitat Sima E, Hedberg J, Ehrenborg A, Sundbom M (2014) Differences in early complications between circular and linear stapled gastrojejunostomy in laparoscopic gastric bypass. Obes Surg 24:599–603PubMedCrossRef Sima E, Hedberg J, Ehrenborg A, Sundbom M (2014) Differences in early complications between circular and linear stapled gastrojejunostomy in laparoscopic gastric bypass. Obes Surg 24:599–603PubMedCrossRef
6.
Zurück zum Zitat Munoz-Flores F, Rodriguez-Quintero JH, Pechman D, Creange C, Zenilman A, Choi J et al (2022) Weight loss one year after laparoscopic roux-en-Y gastric bypass is not dependent on the type of gastrojejunal anastomosis. Surg Endosc 36:787–792PubMedCrossRef Munoz-Flores F, Rodriguez-Quintero JH, Pechman D, Creange C, Zenilman A, Choi J et al (2022) Weight loss one year after laparoscopic roux-en-Y gastric bypass is not dependent on the type of gastrojejunal anastomosis. Surg Endosc 36:787–792PubMedCrossRef
7.
Zurück zum Zitat Edholm D (2019) Systematic review and meta-analysis of circular- and linear-stapled gastro-jejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg 29:1946–1953PubMedCrossRef Edholm D (2019) Systematic review and meta-analysis of circular- and linear-stapled gastro-jejunostomy in laparoscopic Roux-en-Y gastric bypass. Obes Surg 29:1946–1953PubMedCrossRef
8.
Zurück zum Zitat Fehervari M, Alyaqout K, Lairy A, Khwaja H, Bonanomi G, Efthimiou E (2021) Gastrojejunal anastomotic technique. Does it matter? Weight loss and weight regain 5 years after laparoscopic Roux-en-Y gastric bypass. Obes Surg 31:267–73PubMedCrossRef Fehervari M, Alyaqout K, Lairy A, Khwaja H, Bonanomi G, Efthimiou E (2021) Gastrojejunal anastomotic technique. Does it matter? Weight loss and weight regain 5 years after laparoscopic Roux-en-Y gastric bypass. Obes Surg 31:267–73PubMedCrossRef
9.
Zurück zum Zitat Shope TR, Cooney RN, McLeod J, Miller CA, Haluck RS (2003) Early results after laparoscopic gastric bypass: EEA vs GIA stapled gastrojejunal anastomosis. Obes Surg 13:355–359PubMedCrossRef Shope TR, Cooney RN, McLeod J, Miller CA, Haluck RS (2003) Early results after laparoscopic gastric bypass: EEA vs GIA stapled gastrojejunal anastomosis. Obes Surg 13:355–359PubMedCrossRef
10.
Zurück zum Zitat Burla L, Weibel P, Baum C, Huber M, Gürtler T, Weber M (2020) Linear versus circular stapler for gastrojejunal anastomosis in laparoscopic Roux-En-Y gastric bypass: an analysis of 211 cases. Surg Res Pract 2020:4090797PubMedPubMedCentral Burla L, Weibel P, Baum C, Huber M, Gürtler T, Weber M (2020) Linear versus circular stapler for gastrojejunal anastomosis in laparoscopic Roux-En-Y gastric bypass: an analysis of 211 cases. Surg Res Pract 2020:4090797PubMedPubMedCentral
11.
Zurück zum Zitat Schneider R, Gass J-M, Kern B, Peters T, Slawik M, Gebhart M et al (2016) Linear compared to circular stapler anastomosis in laparoscopic Roux-en-Y gastric bypass leads to comparable weight loss with fewer complications: a matched pair study. Langenbecks Arch Surg 401:307–313PubMedCrossRef Schneider R, Gass J-M, Kern B, Peters T, Slawik M, Gebhart M et al (2016) Linear compared to circular stapler anastomosis in laparoscopic Roux-en-Y gastric bypass leads to comparable weight loss with fewer complications: a matched pair study. Langenbecks Arch Surg 401:307–313PubMedCrossRef
12.
Zurück zum Zitat Roemer N, Hauswirth F, Teuber H, Teuben M, Neff TA, Muller MK (2022) Improved clinical and financial outcomes in proximal gastric bypass surgery following the transition from a conventional circular stapling to an augmented linear stapling protocol. Obes Surg 32:1601–1609PubMedCrossRef Roemer N, Hauswirth F, Teuber H, Teuben M, Neff TA, Muller MK (2022) Improved clinical and financial outcomes in proximal gastric bypass surgery following the transition from a conventional circular stapling to an augmented linear stapling protocol. Obes Surg 32:1601–1609PubMedCrossRef
13.
Zurück zum Zitat Stenberg E, Szabo E, Ågren G, Ottosson J, Marsk R, Lönroth H et al (2016) Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet Lond Engl 387:1397–1404CrossRef Stenberg E, Szabo E, Ågren G, Ottosson J, Marsk R, Lönroth H et al (2016) Closure of mesenteric defects in laparoscopic gastric bypass: a multicentre, randomised, parallel, open-label trial. Lancet Lond Engl 387:1397–1404CrossRef
14.
Zurück zum Zitat Kristensen SD, Gormsen J, Naver L, Helgstrand F, Floyd AK (2021) Randomized clinical trial on closure versus non-closure of mesenteric defects during laparoscopic gastric bypass surgery. Br J Surg 108:145–151PubMedCrossRef Kristensen SD, Gormsen J, Naver L, Helgstrand F, Floyd AK (2021) Randomized clinical trial on closure versus non-closure of mesenteric defects during laparoscopic gastric bypass surgery. Br J Surg 108:145–151PubMedCrossRef
15.
Zurück zum Zitat Schneider R, Schulenburg M, Kraljević M, Klasen JM, Peters T, Wölnerhanssen B et al (2021) Does the non-absorbable suture closure of the jejunal mesenteric defect reduce the incidence and severity of internal hernias after laparoscopic Roux-en-Y gastric bypass? Langenbecks Arch Surg 406:1831–1838PubMedPubMedCentralCrossRef Schneider R, Schulenburg M, Kraljević M, Klasen JM, Peters T, Wölnerhanssen B et al (2021) Does the non-absorbable suture closure of the jejunal mesenteric defect reduce the incidence and severity of internal hernias after laparoscopic Roux-en-Y gastric bypass? Langenbecks Arch Surg 406:1831–1838PubMedPubMedCentralCrossRef
16.
Zurück zum Zitat Munier P, Alratrout H, Siciliano I, Keller P (2018) Bidirectional jejunojejunal anastomosis prevents early small bowel obstruction due to the kinking after closure of the mesenteric defect in the laparoscopic Roux-en-Y gastric bypass. Obes Surg 28:1838–1844CrossRef Munier P, Alratrout H, Siciliano I, Keller P (2018) Bidirectional jejunojejunal anastomosis prevents early small bowel obstruction due to the kinking after closure of the mesenteric defect in the laparoscopic Roux-en-Y gastric bypass. Obes Surg 28:1838–1844CrossRef
17.
Zurück zum Zitat Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentralCrossRef Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Staiger RD, Cimino M, Javed A, Biondo S, Fondevila C, Périnel J et al (2018) The Comprehensive Complication Index (CCI®) is a novel cost assessment tool for surgical procedures. Ann Surg 268:784–791CrossRef Staiger RD, Cimino M, Javed A, Biondo S, Fondevila C, Périnel J et al (2018) The Comprehensive Complication Index (CCI®) is a novel cost assessment tool for surgical procedures. Ann Surg 268:784–791CrossRef
19.
Zurück zum Zitat Olbers T, Lönroth H, Fagevik-Olsén M, Lundell L (2003) Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 13:364–370CrossRef Olbers T, Lönroth H, Fagevik-Olsén M, Lundell L (2003) Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg 13:364–370CrossRef
20.
Zurück zum Zitat Weber M, Müller MK, Bucher T, Wildi S, Dindo D, Horber F et al (2004) Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 240:975–82 (discussion 982-983)PubMedPubMedCentralCrossRef Weber M, Müller MK, Bucher T, Wildi S, Dindo D, Horber F et al (2004) Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 240:975–82 (discussion 982-983)PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Weber M, Müller MK, Michel J-M, Belal R, Horber F, Hauser R et al (2003) Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg 238:827–33 (discussion 833-834)PubMedPubMedCentralCrossRef Weber M, Müller MK, Michel J-M, Belal R, Horber F, Hauser R et al (2003) Laparoscopic Roux-en-Y gastric bypass, but not rebanding, should be proposed as rescue procedure for patients with failed laparoscopic gastric banding. Ann Surg 238:827–33 (discussion 833-834)PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Müller MK, Wildi S, Clavien P-A, Weber M (2006) New device for the introduction of a circular stapler in laparoscopic gastric bypass surgery. Obes Surg 16:1559–1562PubMedCrossRef Müller MK, Wildi S, Clavien P-A, Weber M (2006) New device for the introduction of a circular stapler in laparoscopic gastric bypass surgery. Obes Surg 16:1559–1562PubMedCrossRef
23.
Zurück zum Zitat Vetter D, Raptis DA, Giama M, Hosa H, Muller MK, Nocito A et al (2017) Planned secondary wound closure at the circular stapler insertion site after laparoscopic gastric bypass reduces postoperative morbidity, costs, and hospital stay. Langenbecks Arch Surg 402:1255–1262PubMedCrossRef Vetter D, Raptis DA, Giama M, Hosa H, Muller MK, Nocito A et al (2017) Planned secondary wound closure at the circular stapler insertion site after laparoscopic gastric bypass reduces postoperative morbidity, costs, and hospital stay. Langenbecks Arch Surg 402:1255–1262PubMedCrossRef
24.
Zurück zum Zitat Stenberg E, dos Reis Falcão LF, O’Kane M, Liem R, Pournaras DJ, Salminen P et al (2022) Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg 46:729–751PubMedPubMedCentralCrossRef Stenberg E, dos Reis Falcão LF, O’Kane M, Liem R, Pournaras DJ, Salminen P et al (2022) Guidelines for perioperative care in bariatric surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations: A 2021 Update. World J Surg 46:729–751PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Gero D, Raptis DA, Vleeschouwers W, van Veldhuisen SL, Martin AS, Xiao Y et al (2019) Defining global benchmarks in bariatric surgery: a retrospective multicenter analysis of minimally invasive Roux-en-Y gastric bypass and sleeve gastrectomy. Ann Surg 270:859–867PubMedCrossRef Gero D, Raptis DA, Vleeschouwers W, van Veldhuisen SL, Martin AS, Xiao Y et al (2019) Defining global benchmarks in bariatric surgery: a retrospective multicenter analysis of minimally invasive Roux-en-Y gastric bypass and sleeve gastrectomy. Ann Surg 270:859–867PubMedCrossRef
26.
Zurück zum Zitat Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien P-A (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7PubMedCrossRef Slankamenac K, Graf R, Barkun J, Puhan MA, Clavien P-A (2013) The comprehensive complication index: a novel continuous scale to measure surgical morbidity. Ann Surg 258:1–7PubMedCrossRef
27.
Zurück zum Zitat Clavien P-A, Vetter D, Staiger RD, Slankamenac K, Mehra T, Graf R et al (2017) The Comprehensive Complication Index (CCI®): added value and clinical perspectives 3 years “Down the Line.” Ann Surg 265:1045–1050PubMedCrossRef Clavien P-A, Vetter D, Staiger RD, Slankamenac K, Mehra T, Graf R et al (2017) The Comprehensive Complication Index (CCI®): added value and clinical perspectives 3 years “Down the Line.” Ann Surg 265:1045–1050PubMedCrossRef
28.
Zurück zum Zitat Kalt F, Mayr H, Gero D (2023) Classification of adverse events in adult surgery. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Kinderchir 33:120–128 Kalt F, Mayr H, Gero D (2023) Classification of adverse events in adult surgery. Eur J Pediatr Surg Off J Austrian Assoc Pediatr Surg Al Z Kinderchir 33:120–128
29.
Zurück zum Zitat Domenghino A, Walbert C, Birrer DL, Puhan MA, Clavien P-A (2023) Outcome4Medicine consensus group. Consensus recommendations on how to assess the quality of surgical interventions. Nat Med 29:811–22PubMedCrossRef Domenghino A, Walbert C, Birrer DL, Puhan MA, Clavien P-A (2023) Outcome4Medicine consensus group. Consensus recommendations on how to assess the quality of surgical interventions. Nat Med 29:811–22PubMedCrossRef
30.
Zurück zum Zitat Gero D, Vannijvel M, Okkema S, Deleus E, Lloyd A, Lo Menzo E et al (2021) Defining Global Benchmarks in Elective Secondary Bariatric Surgery Comprising Conversional, Revisional, and Reversal Procedures. Ann Surg 274:821–828PubMedCrossRef Gero D, Vannijvel M, Okkema S, Deleus E, Lloyd A, Lo Menzo E et al (2021) Defining Global Benchmarks in Elective Secondary Bariatric Surgery Comprising Conversional, Revisional, and Reversal Procedures. Ann Surg 274:821–828PubMedCrossRef
31.
Zurück zum Zitat Teixeira H, Halvachizadeh S, Teuben MPJ, Probst P, Muller MK (2022) Transition from a circular to a linear stapling protocol in laparoscopic Roux-en-Y gastric bypass surgery and its impact on quality of life: a 5-year outcome study. Langenbecks Arch Surg 407:3341–3348PubMedCrossRef Teixeira H, Halvachizadeh S, Teuben MPJ, Probst P, Muller MK (2022) Transition from a circular to a linear stapling protocol in laparoscopic Roux-en-Y gastric bypass surgery and its impact on quality of life: a 5-year outcome study. Langenbecks Arch Surg 407:3341–3348PubMedCrossRef
32.
Zurück zum Zitat Hu Z, Sun J, Li R, Wang Z, Ding H, Zhu T et al (2020) A comprehensive comparison of LRYGB and LSG in obese patients including the effects on QoL, comorbidities, weight loss, and complications: a systematic review and meta-analysis. Obes Surg 30:819–827PubMedCrossRef Hu Z, Sun J, Li R, Wang Z, Ding H, Zhu T et al (2020) A comprehensive comparison of LRYGB and LSG in obese patients including the effects on QoL, comorbidities, weight loss, and complications: a systematic review and meta-analysis. Obes Surg 30:819–827PubMedCrossRef
33.
Zurück zum Zitat Chang S-H, Freeman NLB, Lee JA, Stoll CRT, Calhoun AJ, Eagon JC et al (2018) Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes 19:529–537CrossRef Chang S-H, Freeman NLB, Lee JA, Stoll CRT, Calhoun AJ, Eagon JC et al (2018) Early major complications after bariatric surgery in the USA, 2003–2014: a systematic review and meta-analysis. Obes Rev Off J Int Assoc Study Obes 19:529–537CrossRef
34.
Zurück zum Zitat Almby K, Edholm D (2019) Anastomotic strictures after Roux-en-Y Gastric bypass: a cohort study from the Scandinavian Obesity Surgery Registry. Obes Surg 29:172–177PubMedCrossRef Almby K, Edholm D (2019) Anastomotic strictures after Roux-en-Y Gastric bypass: a cohort study from the Scandinavian Obesity Surgery Registry. Obes Surg 29:172–177PubMedCrossRef
35.
Zurück zum Zitat Barr AC, Lak KL, Helm MC, Kindel TL, Higgins RM, Gould JC (2019) Linear vs. circular-stapled gastrojejunostomy in Roux-en-Y gastric bypass. Surg Endosc 33:4098–101PubMedCrossRef Barr AC, Lak KL, Helm MC, Kindel TL, Higgins RM, Gould JC (2019) Linear vs. circular-stapled gastrojejunostomy in Roux-en-Y gastric bypass. Surg Endosc 33:4098–101PubMedCrossRef
36.
Zurück zum Zitat Vines L, Frick T, Aczél S, L’Allemand D, Borovicka J, Schiesser M (2017) Linear stapled gastrojejunostomy results in fewer strictures compared to circular stapled gastrojejunostomy in laparoscopic gastric bypass surgery. Langenbecks Arch Surg 402:911–916PubMedCrossRef Vines L, Frick T, Aczél S, L’Allemand D, Borovicka J, Schiesser M (2017) Linear stapled gastrojejunostomy results in fewer strictures compared to circular stapled gastrojejunostomy in laparoscopic gastric bypass surgery. Langenbecks Arch Surg 402:911–916PubMedCrossRef
37.
Zurück zum Zitat Vitiello A, Berardi G, Velotti N, Schiavone V, Manetti C, Musella M (2022) Linear versus circular laparoscopic gastrojejunal anastomosis of Roux-en-Y gastric bypass: systematic review and meta-analysis of 22 comparative studies. Surg Laparosc Endosc Percutan Tech 32:393–398PubMedCrossRef Vitiello A, Berardi G, Velotti N, Schiavone V, Manetti C, Musella M (2022) Linear versus circular laparoscopic gastrojejunal anastomosis of Roux-en-Y gastric bypass: systematic review and meta-analysis of 22 comparative studies. Surg Laparosc Endosc Percutan Tech 32:393–398PubMedCrossRef
38.
Zurück zum Zitat Romeijn MM, van Hoef S, Janssen L, van de Pas KGH, van Dielen FMH, Luijten AAPM et al (2021) Comparison of linear versus circular-stapled gastroenterostomy in Roux-en-Y gastric bypass: a nationwide population-based cohort study. Obes Surg 31:3579–3587PubMedCentralCrossRef Romeijn MM, van Hoef S, Janssen L, van de Pas KGH, van Dielen FMH, Luijten AAPM et al (2021) Comparison of linear versus circular-stapled gastroenterostomy in Roux-en-Y gastric bypass: a nationwide population-based cohort study. Obes Surg 31:3579–3587PubMedCentralCrossRef
39.
Zurück zum Zitat Shabino PJ, Khoraki J, Elegbede AF, Schmocker RK, Nabozny MJ, Funk LM et al (2016) Reduction of surgical site infections after laparoscopic gastric bypass with circular stapled gastrojejunostomy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 12:4–9CrossRef Shabino PJ, Khoraki J, Elegbede AF, Schmocker RK, Nabozny MJ, Funk LM et al (2016) Reduction of surgical site infections after laparoscopic gastric bypass with circular stapled gastrojejunostomy. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 12:4–9CrossRef
40.
Zurück zum Zitat Hajibandeh S, Hajibandeh S, Abdelkarim M, Shehadeh A, Mohsin MM, Khan KA et al (2020) Closure versus non-closure of mesenteric defects in laparoscopic Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Endosc 34:3306–3320PubMedCrossRef Hajibandeh S, Hajibandeh S, Abdelkarim M, Shehadeh A, Mohsin MM, Khan KA et al (2020) Closure versus non-closure of mesenteric defects in laparoscopic Roux-en-Y gastric bypass: a systematic review and meta-analysis. Surg Endosc 34:3306–3320PubMedCrossRef
41.
Zurück zum Zitat Magouliotis DE, Tzovaras G, Tasiopoulou VS, Christodoulidis G, Zacharoulis D (2020) Closure of mesenteric defects in laparoscopic gastric bypass: a meta-analysis. Obes Surg 30:1935–1943PubMedCrossRef Magouliotis DE, Tzovaras G, Tasiopoulou VS, Christodoulidis G, Zacharoulis D (2020) Closure of mesenteric defects in laparoscopic gastric bypass: a meta-analysis. Obes Surg 30:1935–1943PubMedCrossRef
42.
Zurück zum Zitat Vatansev C, Belviranli M, Aksoy F, Tuncer S, Sahin M, Karahan O (2002) The effects of different hernia repair methods on postoperative pain medication and CRP levels. Surg Laparosc Endosc Percutan Tech 12:243–246PubMedCrossRef Vatansev C, Belviranli M, Aksoy F, Tuncer S, Sahin M, Karahan O (2002) The effects of different hernia repair methods on postoperative pain medication and CRP levels. Surg Laparosc Endosc Percutan Tech 12:243–246PubMedCrossRef
43.
Zurück zum Zitat Villard MA, Helm MC, Kindel TL, Goldblatt MI, Gould JC, Higgins RM (2019) C-Reactive protein as a predictor of post-operative complications in bariatric surgery patients. Surg Endosc 33:2479–2484PubMedCrossRef Villard MA, Helm MC, Kindel TL, Goldblatt MI, Gould JC, Higgins RM (2019) C-Reactive protein as a predictor of post-operative complications in bariatric surgery patients. Surg Endosc 33:2479–2484PubMedCrossRef
44.
Zurück zum Zitat Bona D, Micheletto G, Bonitta G, Panizzo V, Cavalli M, Rausa E et al (2019) Does C-reactive protein have a predictive role in the early diagnosis of postoperative complications after bariatric surgery? Systematic Review and Bayesian Meta-analysis. Obes Surg 29:3448–3456PubMedCrossRef Bona D, Micheletto G, Bonitta G, Panizzo V, Cavalli M, Rausa E et al (2019) Does C-reactive protein have a predictive role in the early diagnosis of postoperative complications after bariatric surgery? Systematic Review and Bayesian Meta-analysis. Obes Surg 29:3448–3456PubMedCrossRef
45.
Zurück zum Zitat Edholm D, Sundbom M (2015) Comparison between circular- and linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass–a cohort from the Scandinavian Obesity Registry. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 11:1233–1236CrossRef Edholm D, Sundbom M (2015) Comparison between circular- and linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass–a cohort from the Scandinavian Obesity Registry. Surg Obes Relat Dis Off J Am Soc Bariatr Surg 11:1233–1236CrossRef
46.
Zurück zum Zitat Fakas S, Elias M, Lim D, Meytes V (2021) Comparison of gastrojejunostomy techniques and anastomotic complications: a systematic literature review. Surg Endosc 35:6489–6496PubMedCrossRef Fakas S, Elias M, Lim D, Meytes V (2021) Comparison of gastrojejunostomy techniques and anastomotic complications: a systematic literature review. Surg Endosc 35:6489–6496PubMedCrossRef
Metadaten
Titel
Comparative analysis of linear- and circular-stapled gastrojejunostomies in Roux-en-Y gastric bypass: a focus on postoperative morbidity using the comprehensive complication index
verfasst von
Floni Sadiku
Daniela Alceste
Michele Serra
Stefanie Josefine Hehl
Daniel Gero
Andreas Thalheimer
Marco Bueter
Jeannette Widmer
Publikationsdatum
01.12.2024
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 1/2024
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-024-03303-1

Weitere Artikel der Ausgabe 1/2024

Langenbeck's Archives of Surgery 1/2024 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.